NCT02226276 2026-02-13
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
Phase NA Active not recruiting
City of Hope Medical Center
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
University of Utah
University of Washington
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University of Washington
Vanderbilt-Ingram Cancer Center
Stanford University
Children's Hospital of Philadelphia